1. Home
  2. RGNX vs MLP Comparison

RGNX vs MLP Comparison

Compare RGNX & MLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • MLP
  • Stock Information
  • Founded
  • RGNX 2008
  • MLP 1909
  • Country
  • RGNX United States
  • MLP United States
  • Employees
  • RGNX N/A
  • MLP N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • MLP Real Estate
  • Sector
  • RGNX Health Care
  • MLP Finance
  • Exchange
  • RGNX Nasdaq
  • MLP Nasdaq
  • Market Cap
  • RGNX 387.0M
  • MLP 411.7M
  • IPO Year
  • RGNX 2015
  • MLP 1972
  • Fundamental
  • Price
  • RGNX $6.76
  • MLP $17.52
  • Analyst Decision
  • RGNX Strong Buy
  • MLP
  • Analyst Count
  • RGNX 9
  • MLP 0
  • Target Price
  • RGNX $32.89
  • MLP N/A
  • AVG Volume (30 Days)
  • RGNX 1.0M
  • MLP 15.3K
  • Earning Date
  • RGNX 05-07-2025
  • MLP 05-12-2025
  • Dividend Yield
  • RGNX N/A
  • MLP N/A
  • EPS Growth
  • RGNX N/A
  • MLP N/A
  • EPS
  • RGNX N/A
  • MLP N/A
  • Revenue
  • RGNX $83,328,000.00
  • MLP $11,565,000.00
  • Revenue This Year
  • RGNX $285.14
  • MLP N/A
  • Revenue Next Year
  • RGNX N/A
  • MLP N/A
  • P/E Ratio
  • RGNX N/A
  • MLP N/A
  • Revenue Growth
  • RGNX N/A
  • MLP 5.96
  • 52 Week Low
  • RGNX $5.62
  • MLP $17.02
  • 52 Week High
  • RGNX $21.19
  • MLP $26.46
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 41.59
  • MLP 35.89
  • Support Level
  • RGNX $7.96
  • MLP $17.76
  • Resistance Level
  • RGNX $8.35
  • MLP $18.85
  • Average True Range (ATR)
  • RGNX 0.65
  • MLP 0.44
  • MACD
  • RGNX -0.04
  • MLP 0.01
  • Stochastic Oscillator
  • RGNX 13.21
  • MLP 11.92

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About MLP Maui Land & Pineapple Company Inc.

Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales: , which includes land planning and entitlement, development, and sales activities.; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.

Share on Social Networks: